|
English
|
正體中文
|
简体中文
|
2815992
|
|
???header.visitor??? :
27538074
???header.onlineuser??? :
1431
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"stammberger u"???jsp.browse.items-by-author.description???
Showing items 1-7 of 7 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國立成功大學 |
2022 |
Phase Ib/II study of ceritinib in combination with ribociclib in patients with ALK-rearranged non–small cell lung cancer
|
Santoro, A.;Su, W.-C.;Navarro, A.;Simonelli, M.;CH, Yang J.;Ardizzoni, Ardizzoni A.;Barlesi, F.;Hyoung, Kang J.;DiDominick, S.;Abdelhady, Abdelhady A.;Chen, X.;Stammberger, U.;Felip, E. |
| 臺大學術典藏 |
2021-08-31T06:29:31Z |
Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma
|
Bouattour M.; Raymond E.; Qin S.; ANN-LII CHENG; Stammberger U.; Locatelli G.; Faivre S. |
| 臺大學術典藏 |
2021-03-10T02:36:30Z |
Phase ib study of ribociclib plus fulvestrant and ribociclib plus fulvestrant plus pi3k inhibitor (alpelisib or buparlisib) for HR? advanced breast cancer
|
Tolaney S.M.; Im Y.-H.; Calvo E.; YEN-SHEN LU; Hamilton E.; Forero-Torres A.; Bachelot T.; Maur M.; Fasolo A.; Tiedt R.; Nardi L.; Stammberger U.; Abdelhady A.M.; Ruan S.; Lee S.C. |
| 臺大學術典藏 |
2020-05-26T09:27:03Z |
Diarrhea associated with afatinib: An oral ErbB family blocker
|
Chih-Hsin Yang;Reguart N;Barinoff J;K?Hler J;Uttenreuther-Fischer M;Stammberger U;O'Brien D;Wolf J;Cohen E.E.; CHIH-HSIN YANG; Reguart N; Barinoff J; Köhler J; Uttenreuther-Fischer M; Stammberger U; O'Brien D; Wolf J; Cohen E.E. |
| 臺大學術典藏 |
2020-05-26T09:27:03Z |
Diarrhea associated with afatinib: An oral ErbB family blocker
|
Chih-Hsin Yang;Reguart N;Barinoff J;K?Hler J;Uttenreuther-Fischer M;Stammberger U;O'Brien D;Wolf J;Cohen E.E.; CHIH-HSIN YANG; Reguart N; Barinoff J; Köhler J; Uttenreuther-Fischer M; Stammberger U; O'Brien D; Wolf J; Cohen E.E. |
| 臺大學術典藏 |
2020-05-26T09:26:58Z |
Afatinib in the treatment of EGFR mutation-positive NSCLC - A network meta-analysis
|
Popat S;Mok T;Chih-Hsin Yang;Wu Y.-L;Lungershausen J;Stammberger U;Griebsch I;Fonseca T;Paz-Ares L.; Popat S; Mok T; CHIH-HSIN YANG; Wu Y.-L; Lungershausen J; Stammberger U; Griebsch I; Fonseca T; Paz-Ares L. |
| 臺大學術典藏 |
2020-05-26T09:26:58Z |
Afatinib in the treatment of EGFR mutation-positive NSCLC - A network meta-analysis
|
Popat S;Mok T;Chih-Hsin Yang;Wu Y.-L;Lungershausen J;Stammberger U;Griebsch I;Fonseca T;Paz-Ares L.; Popat S; Mok T; CHIH-HSIN YANG; Wu Y.-L; Lungershausen J; Stammberger U; Griebsch I; Fonseca T; Paz-Ares L. |
Showing items 1-7 of 7 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
